Sabra Health Care REIT, Inc. - Common stock, $0.01 par value (SBRA) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common stock, $0.01 par value
Symbol
SBRA on Nasdaq
Shares outstanding
237,524,614
Price per share
$18.94
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
231,654,404
Total reported value
$4,316,422,582
% of total 13F portfolios
0%
Share change
-423,478
Value change
-$6,841,690
Number of holders
413
Price from insider filings
$18.94
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Sabra Health Care REIT, Inc. - Common stock, $0.01 par value (SBRA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PRINCIPAL REAL ESTATE INVESTORS LLC 8.3% $349,933,138 19,714,543 PRINCIPAL REAL ESTATE INVESTORS LLC 30 Jun 2025
STATE STREET CORP 5.2% $206,340,334 12,187,852 STATE STREET CORPORATION 31 Dec 2024

As of 30 Sep 2025, 413 institutional investors reported holding 231,654,404 shares of Sabra Health Care REIT, Inc. - Common stock, $0.01 par value (SBRA). This represents 98% of the company’s total 237,524,614 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Sabra Health Care REIT, Inc. - Common stock, $0.01 par value (SBRA) together control 75% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 16% 37,102,028 +1.9% 0.01% $691,581,802
VANGUARD GROUP INC 15% 34,948,785 +0.52% 0.01% $651,445,352
PRINCIPAL FINANCIAL GROUP INC 8.6% 20,521,454 -2.3% 0.19% $382,519,971
STATE STREET CORP 5.1% 12,158,155 -1.1% 0.01% $226,628,009
GEODE CAPITAL MANAGEMENT, LLC 2.9% 6,820,438 +3.1% 0.01% $127,148,166
Engineers Gate Manager LP 2.6% 6,057,996 +91% 1.3% $112,921,046
Nuveen, LLC 2.4% 5,678,182 +45% 0.03% $105,841,313
BANK OF AMERICA CORP /DE/ 2.2% 5,224,116 +9.4% 0.01% $97,377,531
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.8% 4,388,809 -1.3% 0.01% $81,807,400
Bank of New York Mellon Corp 1.7% 4,039,454 -3.2% 0.01% $75,295,422
NORTHERN TRUST CORP 1.7% 3,930,245 +1.1% 0.01% $73,259,765
LSV ASSET MANAGEMENT 1.5% 3,618,915 -4.1% 0.15% $67,457,000
JPMORGAN CHASE & CO 1.5% 3,589,253 +34% 0% $66,903,694
DIMENSIONAL FUND ADVISORS LP 1.4% 3,399,083 +2.4% 0.01% $63,358,420
FMR LLC 1.4% 3,297,327 +268% 0% $61,462,190
JANUS HENDERSON GROUP PLC 1.3% 3,089,623 -3.2% 0.03% $57,605,063
APG Asset Management US Inc. 1.3% 2,992,091 0% 0.41% $54,934,791
BANK OF MONTREAL /CAN/ 1.2% 2,787,655 +8.2% 0.02% $51,961,890
DUFF & PHELPS INVESTMENT MANAGEMENT CO 1% 2,472,988 -3% 0.52% $46,096,496
Invesco Ltd. 1% 2,456,130 +4.3% 0.01% $45,782,263
Advisors Capital Management, LLC 0.97% 2,309,654 +2.8% 0.53% $43,051,957
SYSTEMATIC FINANCIAL MANAGEMENT LP 0.97% 2,303,714 -0.93% 1% $42,941,253
MORGAN STANLEY 0.86% 2,053,919 -2.2% 0% $38,285,078
SCHRODER INVESTMENT MANAGEMENT GROUP 0.84% 1,994,739 +38% 0.03% $37,062,251
VICTORY CAPITAL MANAGEMENT INC 0.69% 1,640,821 +8.2% 0.02% $30,584,904

Institutional Holders of Sabra Health Care REIT, Inc. - Common stock, $0.01 par value (SBRA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,441,049 $27,267,831 +$285,050 $18.94 18
2025 Q3 231,654,404 $4,316,422,582 -$6,841,690 $18.64 413
2025 Q2 232,174,374 $4,280,616,068 +$134,043,233 $18.44 386
2025 Q1 225,277,294 $3,936,141,412 -$74,226,395 $17.47 395
2024 Q4 228,711,750 $3,960,824,148 +$82,976,523 $17.32 382
2024 Q3 222,659,952 $4,143,090,172 +$193,449,393 $18.61 371
2024 Q2 211,875,654 $3,262,884,889 +$22,448,779 $15.40 353
2024 Q1 209,101,475 $3,087,936,503 +$7,588,135 $14.77 330
2023 Q4 260,172 $3,712,654 -$3,930,389 $14.27 4
2023 Q3 209,521,757 $2,920,925,697 +$155,884,437 $13.94 321
2023 Q2 194,247,586 $2,286,172,544 -$93,202,518 $11.77 316
2023 Q1 202,243,513 $2,325,555,873 +$30,990,088 $11.50 312
2022 Q4 204,903,346 $2,547,457,279 +$5,445,269 $12.43 317
2022 Q3 201,448,445 $2,642,820,864 -$10,951,229 $13.12 304
2022 Q2 203,391,013 $2,841,477,665 +$78,738,985 $13.97 304
2022 Q1 197,904,006 $2,944,480,291 +$52,323,747 $14.89 299
2021 Q4 195,852,476 $2,652,253,246 +$13,507,770 $13.54 311
2021 Q3 195,360,316 $2,878,601,350 -$23,139,280 $14.72 305
2021 Q2 195,492,344 $3,558,327,375 +$172,632,636 $18.20 299
2021 Q1 190,219,658 $3,304,009,298 +$36,761,635 $17.36 319
2020 Q4 184,439,174 $3,203,304,598 +$82,827,022 $17.37 298
2020 Q3 187,239,662 $2,582,591,142 -$6,748,519 $13.78 297
2020 Q2 187,492,217 $2,704,668,779 +$142,659,891 $14.43 291
2020 Q1 177,849,126 $1,941,967,030 -$84,752,341 $10.92 293
2019 Q4 179,217,418 $3,823,317,871 +$81,771,770 $21.34 347
2019 Q3 171,338,801 $3,934,545,547 +$130,374,615 $22.96 291
2019 Q2 169,734,202 $3,342,627,429 +$248,403,327 $19.69 291
2019 Q1 158,602,343 $3,088,775,650 +$157,851,935 $19.47 302
2018 Q4 144,797,885 $2,385,919,956 -$191,415,881 $16.48 328
2018 Q3 166,321,990 $3,844,148,465 +$93,230,496 $23.12 317
2018 Q2 162,549,306 $3,534,374,697 +$153,805,858 $21.73 315
2018 Q1 158,376,049 $2,797,259,188 +$15,540,047 $17.65 306
2017 Q4 157,480,517 $2,955,489,190 +$48,546,308 $18.77 315
2017 Q3 152,263,789 $3,333,325,618 +$1,695,814,306 $21.94 323
2017 Q2 75,198,591 $1,812,216,876 +$236,248,569 $24.10 212
2017 Q1 65,568,238 $1,831,040,645 +$352,904,054 $27.93 193
2016 Q4 62,104,720 $1,516,641,374 +$38,906,389 $24.42 193
2016 Q3 60,113,935 $1,512,668,706 +$2,864,135 $25.18 192
2016 Q2 60,744,269 $1,253,434,697 +$39,161,428 $20.63 183
2016 Q1 58,607,133 $1,177,005,077 -$31,002,746 $20.09 193
2015 Q4 60,095,455 $1,218,029,957 -$16,149,940 $20.23 182
2015 Q3 60,651,785 $1,405,928,481 +$15,194,847 $23.18 194
2015 Q2 58,314,396 $1,499,303,037 +$74,281,959 $25.74 194
2015 Q1 56,157,904 $1,861,092,887 +$107,613,391 $33.15 190
2014 Q4 53,011,127 $1,611,543,012 +$163,550,357 $30.37 199
2014 Q3 48,586,222 $1,181,491,700 +$136,746,407 $24.32 202
2014 Q2 43,347,099 $1,244,433,766 +$207,587,185 $28.71 192
2014 Q1 35,866,148 $1,000,676,187 +$26,173,078 $27.89 184